Computer aided diagnosis for cardiovascular diseases based on ECG signals : a survey

The interpretation of Electroencephalography (ECG) signals is difficult, because even subtle changes in the waveform can indicate a serious heart disease. Furthermore, these waveform changes might not be present all the time. As a consequence, it takes years of training for a medical practitioner to become an expert in ECG-based cardiovascular disease diagnosis. That training is a major investment in a specific skill. Even with expert ability, the signal interpretation takes time. In addition, human interpretation of ECG signals causes interoperator and intraoperator variability. ECG-based Computer-Aided Diagnosis (CAD) holds the promise of improving the diagnosis accuracy and reducing the cost. The same ECG signal will result in the same diagnosis support regardless of time and place. This paper introduces both the techniques used to realize the CAD functionality and the methods used to assess the established functionality. This survey aims to instill trust in CAD of cardiovascular diseases using ECG signals by introducing both a conceptional overview of the system and the necessary assessment method

Longitudinal study on low-dose aspirin versus placebo administration in silent brain infarcts: the silence study

Background. We investigated low-dose aspirin (ASA) efficacy and safety in subjects with silent brain infarcts (SBIs) in preventing new cerebrovascular (CVD) events as well as cognitive impairment. Methods. We included subjects aged ≥45 years, with at least one SBI and no previous CVD. Subjects were followed up to 4 years assessing CVD and SBI incidence as primary endpoint and as secondary endpoints: (a) cardiovascular and adverse events and (b) cognitive impairment. Results. Thirty-six subjects received ASA while 47 were untreated. Primary endpoint occurred in 9 controls (19.1%) versus 2 (5.6%) in the ASA group (p=0.10). Secondary endpoints did not differ in the two groups. Only baseline leukoaraiosis predicts primary [OR 5.4 (95%CI 1.3-22.9, p=0.022)] and secondary endpoint-A [3.2 (95%CI 1.1-9.6, p=0.040)] occurrence. Conclusions. These data show an increase of new CVD events in the untreated group. Despite the study limitations, SBI seems to be a negative prognostic factor and ASA preventive treatment might improve SBI prognosis. EU Clinical trial is registered with EudraCT Number: 2005-000996-16; Sponsor Protocol Number: 694/30.06.04

ECG Quality Assessment via Deep Learning and Data Augmentation

[EN] Quality assessment of ECG signals acquired with wearable devices is essential to avoid misdiagnosis of some cardiac disorders. For that purpose, novel deep learning algorithms have been recently proposed. However, training of these methods require large amount of data and public databases with annotated ECG samples are limited. Hence, the present work aims at validating the usefulness of a well-known data augmentation approach in this context of ECG quality assessment. Precisely, classification between high- and low-quality ECG excerpts achieved by a common convolutional neural network (CNN) trained on two databases has been compared. On the one hand, 2,000 5 second-length ECG excerpts were initially selected from a freely available database. Half of the segments were extracted from noisy ECG recordings and the other half from high-quality signals. On the other hand, using a data augmentation approach based on time-scale modification, noise addition, and pitch shifting of the original noisy ECG experts, 1,000 additional low-quality intervals were generated. These surrogate noisy signals and the original highquality ones formed the second dataset. The results for both cases were compared using a McNemar test and no statistically significant differences were noticed, thus suggesting that the synthesized noisy signals could be used for reliable training of CNN-based ECG quality indices.Huerta, Á.; Martínez-Rodrigo, A.; Rieta, JJ.; Alcaraz, R. (2021). ECG Quality Assessment via Deep Learning and Data Augmentation. 1-4. https://doi.org/10.22489/CinC.2021.2431

Artificial Intelligence-Enabled ECG Algorithm Based on Improved Residual Network for Wearable ECG

Heart disease is the leading cause of death for men and women globally. The residual network (ResNet) evolution of electrocardiogram (ECG) technology has contributed to our understanding of cardiac physiology. We propose an artificial intelligence-enabled ECG algorithm based on an improved ResNet for a wearable ECG. The system hardware consists of a wearable ECG with conductive fabric electrodes, a wireless ECG acquisition module, a mobile terminal App, and a cloud diagnostic platform. The algorithm adopted in this study is based on an improved ResNet for the rapid classification of different types of arrhythmia. First, we visualize ECG data and convert one-dimensional ECG signals into two-dimensional images using Gramian angular fields. Then, we improve the ResNet-50 network model, add multistage shortcut branches to the network, and optimize the residual block. The ReLu activation function is replaced by a scaled exponential linear units (SELUs) activation function to improve the expression ability of the model. Finally, the images are input into the improved ResNet network for classification. The average recognition rate of this classification algorithm against seven types of arrhythmia signals (atrial fibrillation, atrial premature beat, ventricular premature beat, normal beat, ventricular tachycardia, atrial tachycardia, and sinus bradycardia) is 98.3%